2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
3/05/2019 | 9:40 AM - 10:05 AM | Development of an Audiological Evaluation and Monitoring Protocol for Infants and Children with Congenital CMV | Malpensa
Development of an Audiological Evaluation and Monitoring Protocol for Infants and Children with Congenital CMV
Congenital cytomegalovirus (CMV) infection is a leading cause of hearing loss and neurologic disabilities in children. Some complications of infants diagnosed with CMV can include intellectual disability, vision problems, seizures, muscle weakness and hearing loss. Hearing loss is the most common symptom of congenital CMV infection. Therefore, it is important for audiology departments to have a protocol in place for evaluating, monitoring, referring and tracking infants with congenital CMV infection. Development of a clinical protocol for the Department of Audiology at the Ann & Robert H. Lurie Children’s Hospital of Chicago included a review of the literature, interdisciplinary collaboration and clinical consideration. Initially a literature review was completed to determine whether infants with congenital CMV infection without symptoms at birth “asymptomatic” should undergo the same testing and monitoring as those infants with symptoms at birth “symptomatic”. Research indicated that hearing loss in symptomatic infants is more common, more severe in degree and occurs earlier than in asymptomatic infants. However both populations are at risk for late onset and progressive hearing loss. In order to promote early detection and intervention, it was concluded that both symptomatic and asymptomatic infants with congenital CMV should receive frequent audiological monitoring until 5 years of age. Interdisciplinary collaboration for management of all children is one of the founding principles of our hospital and department. Children who are symptomatic at birth receive comprehensive evaluations by the Infectious Disease, Otolaryngology and Ophthalmology. Clinical considerations from previous experience, case studies and current trends were also evaluated and taken into account. The creation of a protocol for standardization of audiological monitoring ensures appropriate management of all infants with CMV, including those that may become symptomatic with a diagnosis of hearing loss.
- Understand congenital CMV infection including how it is diagnosed, possible symptoms and specialties involved in treatment/management
- Identify and describe the difference between a symptomatic and asymptomatic congenital CMV infection
- Review an evidence based protocol for audiological evaluation and monitoring of patients with congenital CMV
Presentation:
18878_10559KristenCortese.pdf
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Kristen Cortese
(Point of Contact,Primary Presenter), Ann & Robert H. Lurie Children's Hospital of Chicago , kcortese@luriechildrens.org;
Kristen Cortese, Au.D., CCC-A has been a pediatric audiologist on the diagnostic team at Ann & Robert H. Lurie Children’s Hospital of Chicago since 2014 after completing her externship with the department from 2013-2014. She received her Bachelor of Science from the University of Illinois in 2010 and her Doctorate of Audiology from Rush University in 2014. During her career she has served as a member of the Evidence Based Practice and Clinical Quality Teams, and is passionate about promoting both elements within patient care. Her professional interests include pediatric diagnostic testing, amplification, electrophysiology, inpatient management and clinical research.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Lisa Weber
(Point of Contact,Co-Presenter), Ann & Robert H. Lurie Children's Hospital of Chicago , lweber@luriechildrens.org;
Lisa Weber Au.D, CCC-A is a graduate of Indiana University. She has practiced audiology specializing in cochlear implants since June 2001. She served as clinical director/cochlear implant program coordinator at an ENT practice in Fort Wayne, Indiana prior to joining the Audiology Department at Ann & Robert H. Lurie Children’s Hospital in October, 2008. Lisa completed her clinical doctorate in Audiology through Salus University in December 2009. In August 2012, Lisa was promoted to Manager of Audiology at Lurie Children's. Although administrative duties take up a majority of her time, she continues to maintain a caseload focusing on patients with hearing loss and specifically those with cochlear implants.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -